ALS' (ASX:ALQ) expected improvement in sampling flows through the second half of fiscal 2025 and further improvement in fiscal 2026 could result in an upside to earnings outlook, Jarden Research said in a note Tuesday.
The company reported statutory earnings of AU$0.26 per share for the first half of the fiscal year 2025, down from AU$0.274 per share a year earlier. Revenue from ordinary activities rose nearly 20% to AU$1.46 billion from AU$1.22 billion a year earlier.
Jarden Research expects a 1% increase in the company's geochemistry sampling volumes and a further 2.8% improvement in fiscal 2026.
"We expect this could be a positive upside risk to our earnings forecasts, all else remaining equal," the investment firm said.
Jarden Research downgraded ALS to neutral from overweight and raised the target price to AU$14.40 from AU$14.25.
The company shares rose over 1% in recent Thursday trade.
Price (AUD): $15.51, Change: $+0.18, Percent Change: +1.14%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。